Literature DB >> 22577156

CyBorD: stellar response rates in AL amyloidosis.

Giampaolo Merlini1.   

Abstract

Entities:  

Year:  2012        PMID： 22577156     DOI： 10.1182/blood-2012-03-413112

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Light chain amyloidosis: the heart of the problem.

Authors:  Giampaolo Merlini; Giovanni Palladini
Journal:  Haematologica       Date:  2013-10       Impact factor: 9.941

Review 2.  New insights and modern treatment of AL amyloidosis.

Authors:  Chakra P Chaulagain; Raymond L Comenzo
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

3.  Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.

Authors:  Yujia Wang; Lushuang Xu; Yang Liu; Yuzhe Hu; Qiang Shi; Lixue Jin; Lijun Yang; Pingzhang Wang; Kunshan Zhang; Xiaojun Huang; Qing Ge; Jin Lu
Journal:  Int J Hematol       Date:  2020-10-10       Impact factor: 2.490

4.  Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells.

Authors:  Torri L Jordan; Khansaa Maar; Keely R Redhage; Pinaki Misra; Luis M Blancas-Mejia; Christopher J Dick; Jonathan S Wall; Angela Williams; Allan B Dietz; Andre J van Wijnen; Yi Lin; Marina Ramirez-Alvarado
Journal:  Leukemia       Date:  2019-12-03       Impact factor: 11.528

5.  Cerebral embolism secondary to cardiac amyloidosis: A case report and literature review.

Authors:  Xu-Dong Zhang; Ying-Xian Liu; Xiao-Wei Yan; Li-Gang Fang; Quan Fang; Da-Chun Zhao; Yi-Ning Wang
Journal:  Exp Ther Med       Date:  2017-10-13       Impact factor: 2.447

6.  Cardiac involvement in heavy and light chain amyloidosis: A case report and literature review.

Authors:  Yukihiro Otaka; Yoichi Nakazato; Takaaki Tsutsui; Jun'ichi Tamura
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Light chain cardiac amyloidosis in a nonagenarian.

Authors:  Koji Takahashi; Mina Yamashita; Tomoki Sakaue; Daijiro Enomoto; Shigeki Uemura; Takafumi Okura; Shuntaro Ikeda; Takanori Senba; Akira Saijo; Nobuhisa Yamamura; Sohei Kitazawa
Journal:  J Geriatr Cardiol       Date:  2022-01-28       Impact factor: 3.327

Review 8.  AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review.

Authors:  Giada Bianchi; Yifei Zhang; Raymond L Comenzo
Journal:  JACC CardioOncol       Date:  2021-10-19

Review 9.  Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.

Authors:  Mathew S Maurer; Preston Dunnmon; Mariana Fontana; Cristina Candida Quarta; Krishna Prasad; Ronald M Witteles; Claudio Rapezzi; James Signorovitch; Isabelle Lousada; Giampaolo Merlini
Journal:  Circ Heart Fail       Date:  2022-03-25       Impact factor: 10.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.